Global disparities in SARS-CoV-2 genomic surveillance
| Autor: | Brito, Anderson F, Semenova, Elizaveta, Dudas, Gytis, Hassler, Gabriel W, Kalinich, Chaney C, Kraemer, Moritz U G, Ho, Joses, Tegally, Houriiyah, Githinji, George, Agoti, Charles N, Matkin, Lucy E, Whittaker, Charles, Howden, Benjamin P, Sintchenko, Vitali, Zuckerman, Neta S, Mor, Orna, Blankenship, Heather M, de Oliveira, Tulio, Lin, Raymond T P, Siqueira, Marilda Mendonça, Resende, Paola Cristina, Vasconcelos, Ana Tereza R, Spilki, Fernando R, Aguiar, Renato Santana, Alexiev, Ivailo, Ivanov, Ivan N, Philipova, Ivva, Carrington, Christine V F, Sahadeo, Nikita S D, Branda, Ben, Gurry, Céline, Maurer-Stroh, Sebastian, Naidoo, Dhamari, von Eije, Karin J, Perkins, Mark D, van Kerkhove, Maria, Hill, Sarah C, Sabino, Ester C, Pybus, Oliver G, Dye, Christopher, Bhatt, Samir, Flaxman, Seth, Suchard, Marc A, Grubaugh, Nathan D, Baele, Guy, Faria, Nuno R |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Multidisciplinary Coronavirus disease 2019 (COVID-19) SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Public health viruses COVID-19 General Physics and Astronomy Genome Viral Genomics General Chemistry Biology sequencing Genome DNA sequencing Virus General Biochemistry Genetics and Molecular Biology Temporal heterogeneity Environmental health Pandemic medicine Humans Pandemics |
| Zdroj: | Nature communications, Berlin : Nature Portfolio, 2022, vol. 13, no. 1, art. no. 7003, p. [1-13] Nature Communications, 13:7003. Nature Publishing Group Communicable Diseases Genomics Network (Australia and New Zealand), COVID-19 Impact Project, Danish Covid-19 Genome Consortium, Fiocruz COVID-19 Genomic Surveillance Network, GISAID core curation team, Network for Genomic Surveillance in South Africa (NGS-SA), Swiss SARS-CoV-2 Sequencing Consortium & Bulgarian SARS-CoV-2 sequencing group 2022, ' Global disparities in SARS-CoV-2 genomic surveillance ', Nature Communications, vol. 13, pp. 7003 . https://doi.org/10.1038/s41467-022-33713-y |
| ISSN: | 2041-1723 |
| DOI: | 10.1101/2021.08.21.21262393 |
| Popis: | Genomic sequencing is essential to track the evolution and spread of SARS-CoV-2, optimize molecular tests, treatments, vaccines, and guide public health responses. To investigate the global SARS-CoV-2 genomic surveillance, we used sequences shared via GISAID to estimate the impact of sequencing intensity and turnaround times on variant detection in 189 countries. In the first two years of the pandemic, 78% of high-income countries sequenced >0.5% of their COVID-19 cases, while 42% of low- and middle-income countries reached that mark. Around 25% of the genomes from high income countries were submitted within 21 days, a pattern observed in 5% of the genomes from low- and middle-income countries. We found that sequencing around 0.5% of the cases, with a turnaround time |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink